Cargando…

Sarcopenic Obesity, the Possible Culprit for Nonalcoholic Fatty Liver Disease or Fibrosis

Detalles Bibliográficos
Autores principales:	Kang, Seong Hee, Yoon, Eileen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840918/ https://www.ncbi.nlm.nih.gov/pubmed/36636885 http://dx.doi.org/10.5009/gnl220543

Ejemplares similares

Association between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis
por: Song, Wolhwa, et al.
Publicado: (2023)

Sarcopenic Obesity in Non-Alcoholic Fatty Liver Disease—The Union of Two Culprits
por: Emhmed Ali, Saad, et al.
Publicado: (2021)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Waiting for Multi-Stakeholders̕ Consensus Position Statement on New Nonalcoholic Fatty Liver Disease Nomenclature
por: Yoon, Eileen L., et al.
Publicado: (2022)

Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
por: Yoon, Eileen Laurel, et al.
Publicado: (2023)

Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Yu, Su Jong, et al.
Publicado: (2015)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Risk factors in nonalcoholic fatty liver disease
por: Ko, Eunji, et al.
Publicado: (2023)

Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease
por: Qadri, Sami, et al.
Publicado: (2021)

Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
por: Chun, Ho Soo, et al.
Publicado: (2023)

Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
por: Han, Eugene, et al.
Publicado: (2023)

Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Body fat distribution: a crucial target for intervention in nonalcoholic fatty liver disease and fibrosis
por: Wijarnpreecha, Karn, et al.
Publicado: (2022)

Diet and Lifestyle in Nonalcoholic Fatty Liver Disease
por: Martínez-Beamonte, Roberto, et al.
Publicado: (2020)

Implications of comorbidities in nonalcoholic fatty liver disease
por: Song, Sherlot Juan, et al.
Publicado: (2023)

Impact of sarcopenic obesity on functional outcomes
por: Shimizu, Akio, et al.
Publicado: (2023)

Sarcopenic obesity: recent consensus and clinical implications in patients with chronic liver disease
por: Merli, Manuela, et al.
Publicado: (2023)

Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
por: Alqahtani, Saleh A., et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease: Its Mechanisms and Complications
por: El Ouaamari, Abdelfattah, et al.
Publicado: (2013)

Noninvasive Markers for the Diagnosis of Nonalcoholic Fatty Liver Disease
por: Kim, Sang Yong
Publicado: (2013)

The utility of ezetimibe therapy in nonalcoholic fatty liver disease
por: Jun, Baek Gyu, et al.
Publicado: (2019)

Role of cenicriviroc in the management of nonalcoholic fatty liver disease
por: Neokosmidis, Georgios, et al.
Publicado: (2018)

Treating Nonalcoholic Fatty Liver Disease From the Outside In?
por: Flynn, Charles R.
Publicado: (2019)

Imaging methods in the assessment of nonalcoholic fatty liver disease
por: Parente, Daniella Braz
Publicado: (2020)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Amjad, Waseem, et al.
Publicado: (2023)

Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”
por: Yoon, Eileen L., et al.
Publicado: (2023)

Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
por: Alam, Shahinul, et al.
Publicado: (2021)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)

Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease
por: Park, Ji Sook, et al.
Publicado: (2013)

The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
por: Park, Ji-Won, et al.
Publicado: (2023)

Hepatic and Splenic Volumetry Could Be Used as an Imaging Parameter to Evaluate Fibrosis Grades of the Diffuse Liver Disease Including Nonalcoholic Fatty Liver Disease
por: Jeong, Woo Kyoung
Publicado: (2017)

Sarcopenic osteoporosis, sarcopenic obesity, and sarcopenic osteoporotic obesity in the Camargo cohort (Cantabria, Spain)
por: Hernández-Martínez, Paula, et al.
Publicado: (2022)

From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
por: Kang, Seong Hee, et al.
Publicado: (2021)

Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?
por: Jang, Heejoon, et al.
Publicado: (2023)

Uncertainty and Diversity in the Methods Defining Sarcopenia and Sarcopenic Obesity
por: Kim, Kyoung Min
Publicado: (2017)

Obesity and nonalcoholic fatty liver disease: current perspectives
por: Sarwar, Raiya, et al.
Publicado: (2018)

Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Buzzetti, Elena, et al.
Publicado: (2015)

Estimation of the risk of fibrosis in children with nonalcoholic fatty liver disease
por: Małecki, Paweł, et al.
Publicado: (2020)

Risk Factors of Nonalcoholic Fatty Liver Disease and Liver Fibrosis in Non-Obese Patients with Obstructive Sleep Apnea
por: Lian, Ningfang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b60s6leondlv31s7m5iiatiosm